-
Mashup Score: 3Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice - 3 month(s) ago
Healthcare data are increasingly collected in transactional systems such as electronic health records (EHRs) and aggregated into analytical systems such as clinical data warehouses (figure 1). Consequently, there has been significant interest in reusing these data for evidence-based practice, research, biosurveillance, quality improvement and other purposes. Despite enthusiasm and multiple successful use cases,1 2 reuse of clinical data remains challenging.3 There are challenges related to data (ie, bits and bytes stored in computer systems), information (ie, meaning of the bits and bytes) and knowledge (ie, conclusions drawn based on analyses of information).4 5 For example, data may be corrupted due to a hardware or software malfunction (data problem). Alternatively, the data may be correct, but the meaning or context may be lost. One famous example of information corruption occurred when institutional EHR data were transferred into a commercial personal health record.6 In that case,
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 23Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic - 3 month(s) ago
The COVID-19 pandemic represents the largest public health crisis of the past century. Faced with a global threat, public health officials, professional societies, clinicians and patients have appropriately sought strategies to prevent SARS-CoV-2 transmission, reduce progression to severe and critical illness, and mitigate short-term and long-term sequelae. Efforts have extended to drug therapies, non-pharmacological interventions (vaccination, ventilation strategies in critically ill) and system-level policies (masking, vaccination, quarantining, isolation, physical distancing, and remote work and study). First reports of cases of pneumonia originating from Wuhan, China, emerged on 31 December 2019. A PubMed search conducted from 1 January 2020 to date using keywords related to coronavirus, COVID-19, SARS-CoV-2 and novel coronavirus-2 yields over 439 000 hits, representing a daily publication rate of over 260 articles. A living systematic review of registered clinical trials for COVID
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic #Analysis by @ArnavAgarwalMD and @GuyattGH Link: https://t.co/CsvZftsmPU https://t.co/Sdp2zmms3t
-
-
Mashup Score: 23Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic - 3 month(s) ago
The COVID-19 pandemic represents the largest public health crisis of the past century. Faced with a global threat, public health officials, professional societies, clinicians and patients have appropriately sought strategies to prevent SARS-CoV-2 transmission, reduce progression to severe and critical illness, and mitigate short-term and long-term sequelae. Efforts have extended to drug therapies, non-pharmacological interventions (vaccination, ventilation strategies in critically ill) and system-level policies (masking, vaccination, quarantining, isolation, physical distancing, and remote work and study). First reports of cases of pneumonia originating from Wuhan, China, emerged on 31 December 2019. A PubMed search conducted from 1 January 2020 to date using keywords related to coronavirus, COVID-19, SARS-CoV-2 and novel coronavirus-2 yields over 439 000 hits, representing a daily publication rate of over 260 articles. A living systematic review of registered clinical trials for COVID
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic #Analysis by @ArnavAgarwalMD and @GuyattGH Link: https://t.co/CsvZftsmPU https://t.co/Sdp2zmms3t
-
-
Mashup Score: 23Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic - 3 month(s) ago
The COVID-19 pandemic represents the largest public health crisis of the past century. Faced with a global threat, public health officials, professional societies, clinicians and patients have appropriately sought strategies to prevent SARS-CoV-2 transmission, reduce progression to severe and critical illness, and mitigate short-term and long-term sequelae. Efforts have extended to drug therapies, non-pharmacological interventions (vaccination, ventilation strategies in critically ill) and system-level policies (masking, vaccination, quarantining, isolation, physical distancing, and remote work and study). First reports of cases of pneumonia originating from Wuhan, China, emerged on 31 December 2019. A PubMed search conducted from 1 January 2020 to date using keywords related to coronavirus, COVID-19, SARS-CoV-2 and novel coronavirus-2 yields over 439 000 hits, representing a daily publication rate of over 260 articles. A living systematic review of registered clinical trials for COVID
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic #Analysis by @ArnavAgarwalMD and @GuyattGH Link: https://t.co/CsvZftsmPU https://t.co/Sdp2zmms3t
-
-
Mashup Score: 3Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice - 3 month(s) ago
Healthcare data are increasingly collected in transactional systems such as electronic health records (EHRs) and aggregated into analytical systems such as clinical data warehouses (figure 1). Consequently, there has been significant interest in reusing these data for evidence-based practice, research, biosurveillance, quality improvement and other purposes. Despite enthusiasm and multiple successful use cases,1 2 reuse of clinical data remains challenging.3 There are challenges related to data (ie, bits and bytes stored in computer systems), information (ie, meaning of the bits and bytes) and knowledge (ie, conclusions drawn based on analyses of information).4 5 For example, data may be corrupted due to a hardware or software malfunction (data problem). Alternatively, the data may be correct, but the meaning or context may be lost. One famous example of information corruption occurred when institutional EHR data were transferred into a commercial personal health record.6 In that case,
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice #Analysis by Bernstam et al. Link: https://t.co/Rz0m7vy6i1 https://t.co/DqoLq0qun0
-
-
Mashup Score: 3Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice - 3 month(s) ago
Healthcare data are increasingly collected in transactional systems such as electronic health records (EHRs) and aggregated into analytical systems such as clinical data warehouses (figure 1). Consequently, there has been significant interest in reusing these data for evidence-based practice, research, biosurveillance, quality improvement and other purposes. Despite enthusiasm and multiple successful use cases,1 2 reuse of clinical data remains challenging.3 There are challenges related to data (ie, bits and bytes stored in computer systems), information (ie, meaning of the bits and bytes) and knowledge (ie, conclusions drawn based on analyses of information).4 5 For example, data may be corrupted due to a hardware or software malfunction (data problem). Alternatively, the data may be correct, but the meaning or context may be lost. One famous example of information corruption occurred when institutional EHR data were transferred into a commercial personal health record.6 In that case,
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice #Analysis by Bernstam et al. Link: https://t.co/Rz0m7vy6i1 https://t.co/DqoLq0qun0
-
-
Mashup Score: 23Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic - 3 month(s) ago
The COVID-19 pandemic represents the largest public health crisis of the past century. Faced with a global threat, public health officials, professional societies, clinicians and patients have appropriately sought strategies to prevent SARS-CoV-2 transmission, reduce progression to severe and critical illness, and mitigate short-term and long-term sequelae. Efforts have extended to drug therapies, non-pharmacological interventions (vaccination, ventilation strategies in critically ill) and system-level policies (masking, vaccination, quarantining, isolation, physical distancing, and remote work and study). First reports of cases of pneumonia originating from Wuhan, China, emerged on 31 December 2019. A PubMed search conducted from 1 January 2020 to date using keywords related to coronavirus, COVID-19, SARS-CoV-2 and novel coronavirus-2 yields over 439 000 hits, representing a daily publication rate of over 260 articles. A living systematic review of registered clinical trials for COVID
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemic #Analysis by @ArnavAgarwalMD and @GuyattGH Link: https://t.co/CsvZftsmPU https://t.co/Sdp2zmms3t
-
-
Mashup Score: 2A call for community-shared decisions - 7 month(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
A call for community-shared decisions #Analysis by Doctor et al. Link: https://t.co/pHcZCl7nF6 https://t.co/pCOW3147Iy
-
-
Mashup Score: 2A call for community-shared decisions - 7 month(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
A call for community-shared decisions #Analysis by Doctor et al. Link: https://t.co/pHcZCl7nF6 https://t.co/pCOW3147Iy
-
-
Mashup Score: 1A call for community-shared decisions - 7 month(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet-
A call for community-shared decisions #Analysis by Doctor et al. Link: https://t.co/pHcZCl7nF6 https://t.co/pCOW3147Iy
-
Informatics hygiene to support reuse of routinely collected health care data for evidence-based practice #Analysis by Bernstam et al. Link: https://t.co/Rz0m7vy6i1 https://t.co/DqoLq0qun0